Since June 2015, Aidan has been an Irish Programme for Stratified Prostate Cancer Therapy (iPROSPECT) Research Fellow at Trinity College Dublin. iPROSPECT, Ireland’s first prostate cancer transformative programme grant, is funded through the Irish Cancer Society in partnership with Movember. In this longitudinal study, under the mentorship of Dr. Antoinette Perry, Aidan aims to identify specific methylation sites, that may be indicative of prognosis, within matched genomic DNA (gDNA) of a cohort of treatment-naïve patients presenting with metastatic prostate cancer.
Aidan was the first PhD graduate of the Prostate Cancer Institute at NUI Galway and was mentored by Prof. Frank Sullivan and Dr. Sharon Glynn. His doctoral thesis “Preclinical Assessment of the Novel Compound EL102 in Prostate Cancer” characterizes the effects of a new class of drug in treating prostate cancer.
He was awarded a Research MSc from NUI Galway under the supervision of Dr. Lynn O’Connor and Prof. Donald McDonnell. To conduct this research, Aidan secured a paid eight month Irish government-funded internship in the lab of Prof. McDonnell at Duke University Medical Center (DUMC), North Carolina. This study identified certain factors influencing the role of androgen receptor (AR) in prostate cancer progression. Aidan also holds a degree in Biochemistry (Hons) from NUI Galway and has worked, for a brief time, at Waterford Institute of Technology, in the fields of novel lung cancer chemotherapy, epithelial-to-mesenchymal transition and biomarker discovery in colorectal cancer.